Core Insights - The National Medical Insurance Administration has announced the results of the latest round of centralized procurement for medicines, with 4,163 products from 1,020 companies obtaining proposed selection qualifications, covering 316 commonly used drugs [1] Group 1: Procurement Details - The procurement includes medicines across 26 therapeutic areas such as anti-infection, anti-tumor, blood sugar reduction, blood pressure reduction, blood lipid reduction, nervous system, respiratory system, and digestive system [1] - The demand matching rate for the reported brands by medical institutions reached 88% [1] - The majority of the clinically used original selected products continue to be selected, with a selection rate of 98% [1] Group 2: Implementation Timeline - This centralized procurement marks the first nationwide unified continuation of chemical drug procurement organized by the state [1] - The results of this procurement are expected to be implemented by the end of March 2026, with the procurement cycle extending until the end of 2028 [1]
涉三百一十六种常用药品！一至八批 国家集采药品接续采购开标
Xin Lang Cai Jing·2026-02-10 20:03